Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer Rafal S Sobota126*, Doreen Ramogola-Masire345, Scott M Williams2 andNicola M Zetola345* Abstract Background The worldwide administration of bivalent and quadrivalent HPV vaccines has resulted in cross-protection against non-vaccine HPV types. Infection with multiple HPV types may offer similar cross-protection […]
Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study
Prevalence Mohammadreza Haghshenas1, Tahereh Golini-moghaddam2, Alireza Rafiei1, Omid Emadeian2, Ahmad Shykhpour1 and G Hossein Ashrafi3* Abstract Background Cervical cancer is the greater cause of cancer death in women in many developing countries. Persistent infection with human papilloma virus (HPV), primarily high risk types 16 and 18, is recognized as a causal and essential factor for the development of cervical cancer. We […]
Opinions on Gardasil clash
By Emma Bailey, The Timaru Herald Girls given the Gardasil HPV vaccine are at least 16 times more likely to have a serious adverse reaction to it than to develop terminal cervical cancer, which critics say raises doubts about the increasingly controversial vaccine. Information obtained by the Timaru Herald under the Official Information Act shows […]
HPV Vaccination Programs, Part one: Understanding the Virus
By Ellen Bown, Contributing Author from the UK The Human papillomavirus (HPV) was first discovered in the 1950’s however, it wasn’t until the 1970’s that some individual strains were first identified[1]. Today we now recognize there are over a 100 different strains of HPV. Each type has been given a different number so it can […]
VAERS HPV Vaccine Adverse Injury Reports through February 13, 2012
Vaccine Adverse Event Reporting System VAERS HPV 4 Gardasil & HPV 2 Cervarix Data collected by HPV Vaccine Research Analyst, Janny Stokvis
